Targeting epigenetic regulators for cancer therapy: mechanisms and advances in clinical trials
Y Cheng, C He, M Wang, X Ma, F Mo, S Yang… - Signal transduction and …, 2019 - nature.com
Epigenetic alternations concern heritable yet reversible changes in histone or DNA
modifications that regulate gene activity beyond the underlying sequence. Epigenetic …
modifications that regulate gene activity beyond the underlying sequence. Epigenetic …
Epigenetics-targeted drugs: Current paradigms and future challenges
W Dai, X Qiao, Y Fang, R Guo, P Bai, S Liu… - … and Targeted Therapy, 2024 - nature.com
Epigenetics governs a chromatin state regulatory system through five key mechanisms: DNA
modification, histone modification, RNA modification, chromatin remodeling, and non-coding …
modification, histone modification, RNA modification, chromatin remodeling, and non-coding …
Targeting metalloenzymes for therapeutic intervention
AY Chen, RN Adamek, BL Dick, CV Credille… - Chemical …, 2018 - ACS Publications
Metalloenzymes are central to a wide range of essential biological activities, including
nucleic acid modification, protein degradation, and many others. The role of metalloenzymes …
nucleic acid modification, protein degradation, and many others. The role of metalloenzymes …
2-Oxoglutarate-dependent oxygenases
MS Islam, TM Leissing, R Chowdhury… - Annual review of …, 2018 - annualreviews.org
2-Oxoglutarate (2OG)-dependent oxygenases (2OGXs) catalyze a remarkably diverse range
of oxidative reactions. In animals, these comprise hydroxylations and N-demethylations …
of oxidative reactions. In animals, these comprise hydroxylations and N-demethylations …
Inhibitors of protein methyltransferases and demethylases
Post-translational modifications of histones by protein methyltransferases (PMTs) and
histone demethylases (KDMs) play an important role in the regulation of gene expression …
histone demethylases (KDMs) play an important role in the regulation of gene expression …
Molecular and cellular mechanisms of HIF prolyl hydroxylase inhibitors in clinical trials
Inhibition of the human 2-oxoglutarate (2OG) dependent hypoxia inducible factor (HIF) prolyl
hydroxylases (human PHD1–3) causes upregulation of HIF, thus promoting erythropoiesis …
hydroxylases (human PHD1–3) causes upregulation of HIF, thus promoting erythropoiesis …
Functional role of G9a histone methyltransferase in cancer
Post-translational modifications of DNA and histones are epigenetic mechanisms, which
affect the chromatin structure, ultimately leading to gene expression changes. A number of …
affect the chromatin structure, ultimately leading to gene expression changes. A number of …
Arginine demethylation is catalysed by a subset of JmjC histone lysine demethylases
LJ Walport, RJ Hopkinson, R Chowdhury… - Nature …, 2016 - nature.com
While the oxygen-dependent reversal of lysine N ɛ-methylation is well established, the
existence of bona fide N ω-methylarginine demethylases (RDMs) is controversial. Lysine …
existence of bona fide N ω-methylarginine demethylases (RDMs) is controversial. Lysine …
Intestinal mucosal barrier repair and immune regulation with an AI-developed gut-restricted PHD inhibitor
Y Fu, X Ding, M Zhang, C Feng, Z Yan, F Wang… - Nature …, 2024 - nature.com
Hypoxia-inducible factor prolyl hydroxylase (PHD) inhibitors have been approved for
treating renal anemia yet have failed clinical testing for inflammatory bowel disease because …
treating renal anemia yet have failed clinical testing for inflammatory bowel disease because …
Human UTY (KDM6C) is a male-specific Nϵ-methyl lysyl demethylase
LJ Walport, RJ Hopkinson, M Vollmar… - Journal of Biological …, 2014 - ASBMB
The Jumonji C lysine demethylases (KDMs) are 2-oxoglutarate-and Fe (II)-dependent
oxygenases. KDM6A (UTX) and KDM6B (JMJD3) are KDM6 subfamily members that …
oxygenases. KDM6A (UTX) and KDM6B (JMJD3) are KDM6 subfamily members that …